Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02053389 · ClinicalTrials.gov registry record · NA
Testing Decision Aids About Early Stage Prostate Cancer
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 564
- Enrollment target
NCT02053389: Completed NA study, sponsored by University of Michigan.
NCT02053389 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 564 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02053389, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 564 participants
- Enrollment target
Study Summary
This is an educational intervention study testing the effects of decision aids in promoting patient participation in early stage prostate cancer treatment decision making. The purpose of this study is to compare patient-physician communication between patients who receive a DVD that models patient communication strategies vs. those who do not receive a DVD. All patients will also receive a written decision aid that describes treatment options for early stage prostate cancer. The Investigators hypothesize that the DVD will: * increase patients' perceptions of the importance of their preferences to their decision making * increase patients' perceptions of their intention to discuss their values and preferences with their urologists and radiation oncologists * increase patients' actual engagement with their physician during the clinical encounter * increase the concordance between patient decision making preferences and actual decision making outcomes * increase long term satisfaction with decision on type of treatment selected * increase patient satisfaction with their decision and the decision making process * influence patient perception of his physician (e.g., trust) and of the diagnosis visit
Primary Outcome
14 item survey instrument
Interventions
- BEHAVIORAL DVD Decision Aid
- BEHAVIORAL Written decision aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 564 participants |
| Start Date | 2010-11 |
| Est. Completion | 2014-02 |
| Phase | NA |
What the finished NCT02053389 record still lists
NCT02053389 is an interventional study that assigns participants to a tested intervention. The registered 564 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (60% lower).
The record links to 0 conditions, and to 2 interventions - of which DVD Decision Aid is the first listed.
NCT02053389 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02053389 about?
NCT02053389 is a clinical study titled "Testing Decision Aids About Early Stage Prostate Cancer". This is an educational intervention study testing the effects of decision aids in promoting patient participation in early stage prostate cancer treatment decision making. The purpose of this study is to compare patient-physician communication between patients who receive a DVD that models patient c...
What is the current status of trial NCT02053389?
This trial is currently completed. It is a NA study. The enrollment target is 564 participants. The study started on 2010-11. Estimated completion is 2014-02.
What interventions are being tested in trial NCT02053389?
The interventions under investigation include: DVD Decision Aid (BEHAVIORAL), Written decision aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT02053389?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02053389's enrollment target sits among peer trials
564 180th of 2000 higher than 1,820 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06146725 · 564 participants
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
- NCT06188520 · 564 participants · Phase 1
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
- NCT06628453 · 564 participants · NA
CGM for Management of Type 2 Diabetes in Pregnancy
- NCT07125326 · 564 participants · NA
How the Method of Bladder Emptying After Epidural Placement in Labor Affects Postpartum Voiding
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia